Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
492.4 USD | -0.11% | -0.59% | -6.46% |
May. 02 | Fortinet projects quarterly billings below estimates as competition heats up | RE |
May. 02 | Factbox-Biggest cyber attacks in US healthcare sector | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The firm trades with high earnings multiples: 27.16 times its 2024 earnings per share.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.46% | 453B | B- | ||
+11.75% | 122B | A- | ||
+14.04% | 97.01B | B- | ||
+0.81% | 39.92B | B- | ||
-29.98% | 38.63B | A- | ||
-5.99% | 19.91B | B- | ||
-14.69% | 3.05B | C+ | ||
-27.00% | 345M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- UNH Stock
- Ratings UnitedHealth Group Inc.